NCT03816345 2026-03-18
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
National Cancer Institute (NCI)
Phase 1 Recruiting
National Cancer Institute (NCI)
Massachusetts General Hospital
Medical University of Gdansk
Ottawa Hospital Research Institute
University Hospital, Clermont-Ferrand